Target intelligence / Profile preview

Death inducer-obliterator 1 (DIDO1)

Target
DIDO1
Molecular classification
Transcription factor, DNA-binding protein, Zinc finger protein
01

Overview

Death inducer-obliterator 1 (DIDO1) is a zinc finger-containing transcription factor encoded by the DIDO1 gene in humans. It is upregulated by apoptotic signals, initially localized in the cytoplasm and translocates to the nucleus upon activation, where it can induce apoptosis and regulate gene expression. DIDO1 functions in several biological processes, including apoptosis, maintenance of chromatin stability, DNA regulation, and the regulation of stem cell pluripotency and differentiation. It has tumor suppressor properties and is involved in normal hematopoiesis, but is also implicated in certain cancers (such as colorectal cancer and melanoma) and hematological malignancies. Overexpression or altered splicing of DIDO1 may contribute to disease development or progression. There are multiple isoforms generated by alternative splicing, and related homologs in other organisms suggest roles beyond apoptosis, particularly linked to chromatin and DNA regulation[1][2][3][4][5].

Other names
DATF1DATF-1BYE1C20orf158DIDO2DIDO3DIO1DIO-1hDido1dJ885L7.8FLJ11265KIAA0333Death-associated transcription factor 1
02

Mechanism of action

Induction of apoptosis (overexpression or upregulation can activate caspase cascades), Tumor suppressor activity, Regulation of stem cell fate, Modulation of DNA/chromatin functions

03

Biological functions

ApoptosisDNA regulationChromatin stabilityCell differentiationStem cell pluripotencyCell cycle
04

Disease associations

CancerMyeloproliferative neoplasmN syndromeHematological malignanciesTumor suppressor function
05

Safety considerations

Potential challenges in targeting DIDO1 directly due to multifunctional roles in apoptosis, cell differentiation, and stem cell maintenancerisk of adverse effects tied to its role in embryonic development and hematopoiesis
06

Interacting drugs

Gambogic acid
07

Biomarkers

Aberrant DIDO1 expression in hematological malignancies and certain cancers

Beyond the preview

Go deeper on Death inducer-obliterator 1 (DIDO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Death inducer-obliterator 1 (DIDO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call